About 6 results found for searched term "Human Transferrin" (0.142 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M10007 | Recombinant Human Holo-Transferrin Protein | Cytokines and Growth Factors |
| Transferrin is iron-binding blood plasma glycoproteins that control the level of free iron in biological fluids. | ||
| M10009 | Recombinant Human Apo-transferrin Protein | Cytokines and Growth Factors |
| Transferrin is iron-binding blood plasma glycoproteins that control the level of free iron in biological fluids. | ||
| M19965 | Human Holo Transferrin | Cell Culture |
| Siderophilin; partially saturated | ||
| Human transferrin is a key nutrient in cultured mammalian cells. Human transferrin is composed of a 77kDa glycoprotein containing 679 amino acids. Iron content: 300-600 PPM. | ||
| M21471 | Recombinant Human Transferrin (HEK293, C-6His) | Cytokines and Growth Factors |
| Serotransferrin; Transferrin; Beta-1 metal-binding globulin | ||
| Recombinant human transferrin is produced by mammalian expression system, and the target gene is encoded as Val20-Pro698, which is expressed by 6His marker at the C-terminal. Protein number: AAA61140.1. | ||
| M24945 | Pabinafusp alfa | Others |
| JR-141 | ||
| Pabinafusp alfa (JR-141) is a transferrin receptor-targeting antibody consisting of Iduronate 2-sulfatase and an anti-human transferrin receptor antibody. Pabinafusp alfa is blood-brain permeable and prevents heparan sulfate (HS) deposition in the central nervous system of mucopolysaccharidosis II (MPS II) mice. Pabinafusp alfa improves learning and prevents central nervous system neuronal damage in mice. | ||
| M54716 | Trontinemab | Amyloid |
| RG6102; RO-7126209 | ||
| Trontinemab is a bispecific human IgG1-κ antibody that targets amyloid β A4 precursor protein (APP) and transferrin receptor (TFRC).Trontinemab may be used in Alzheimer's disease-related studies. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
